Lux Capital: Difference between revisions
Content deleted Content added
No edit summary |
Rescuing 1 sources and tagging 0 as dead. #IABot (v1.6.1) |
||
| Line 1: | Line 1: | ||
'''Lux Capital''' is a [[venture capital]] firm founded by Peter Hébert, Robert Paull, and Josh Wolfe<ref name="Crains">{{cite journal |last1=Fickenscher |first1=Lisa |year=2003 |title=2003 40 Under 40 |journal=Crain's New York Business |volume=Jan 27 - Feb 2, 2003 |pages=15–31 |url=http://mycrains.crainsnewyork.com/40under40/profiles/2003/40 |issn=8756-789X |oclc=11620213}}</ref> in 2000<ref name="Dealmaker">{{cite journal |last1=Eden |first1=Scott |year=2009 |title=Nano Wunderkinds |journal=Dealmaker |volume=December/January 2009 |pages=35–37 |url=https://www.scribd.com/doc/25397940/Dealmaker-Profile-Lux-Capital |issn=1937-304X |oclc=132936538}}</ref> |
'''Lux Capital''' is a [[venture capital]] firm founded by Peter Hébert, Robert Paull, and Josh Wolfe<ref name="Crains">{{cite journal |last1=Fickenscher |first1=Lisa |year=2003 |title=2003 40 Under 40 |journal=Crain's New York Business |volume=Jan 27 - Feb 2, 2003 |pages=15–31 |url=http://mycrains.crainsnewyork.com/40under40/profiles/2003/40 |issn=8756-789X |oclc=11620213 |deadurl=yes |archiveurl=https://web.archive.org/web/20100127033922/http://mycrains.crainsnewyork.com/40under40/profiles/2003/40 |archivedate=2010-01-27 |df= }}</ref> in 2000<ref name="Dealmaker">{{cite journal |last1=Eden |first1=Scott |year=2009 |title=Nano Wunderkinds |journal=Dealmaker |volume=December/January 2009 |pages=35–37 |url=https://www.scribd.com/doc/25397940/Dealmaker-Profile-Lux-Capital |issn=1937-304X |oclc=132936538}}</ref> |
||
. The firm, based in [[New York City]] with an office in [[Menlo Park, California|Menlo Park]], invests in [[emerging technologies]] in the [[physical sciences|physical]] and life sciences.<ref name="BI">{{cite web |url=http://www.businessinsider.com/lux-capital-closes-a-300-million-fund-2015-4 |title=Venture firm Lux just got $350 million more to invests in robots, the future, and science |last=Kosoff |first=Maya |date=2 April 2015 |work=Business Insider |accessdate=8 June 2015}}</ref><ref name="Xcon2">{{cite web |url=https://www.nytimes.com/2015/04/03/business/dealbook/lux-capital-raises-350-million-fund-to-back-science-start-ups.html?_r=0 |title=Lux Capital Raises $350 Million Fund to Back Science Start-Ups |last=de la Merced |first=Michael |date=2 April 2015 |work=New York Times |accessdate=8 June 2015}}</ref> |
. The firm, based in [[New York City]] with an office in [[Menlo Park, California|Menlo Park]], invests in [[emerging technologies]] in the [[physical sciences|physical]] and life sciences.<ref name="BI">{{cite web |url=http://www.businessinsider.com/lux-capital-closes-a-300-million-fund-2015-4 |title=Venture firm Lux just got $350 million more to invests in robots, the future, and science |last=Kosoff |first=Maya |date=2 April 2015 |work=Business Insider |accessdate=8 June 2015}}</ref><ref name="Xcon2">{{cite web |url=https://www.nytimes.com/2015/04/03/business/dealbook/lux-capital-raises-350-million-fund-to-back-science-start-ups.html?_r=0 |title=Lux Capital Raises $350 Million Fund to Back Science Start-Ups |last=de la Merced |first=Michael |date=2 April 2015 |work=New York Times |accessdate=8 June 2015}}</ref> |
||
Revision as of 09:13, 9 January 2018
Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm, based in
Menlo Park, CA , United States | |
| Total assets | $1,400,000,000 |
|---|---|
| Website | luxcapital.com |
About
Lux Capital is a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $1.4 billion in assets across five funds.[5] Lux founded strategic holdings in media, research and policy as proprietary sources of intelligence, access and influence – ensuring that portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competition.The Lux Capital team has built more than 20 companies from scratch.[5]
In April 2011, former
CIA Director James Woolsey joined Lux Capital as venture partners.[6] In August 2012, former Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.[7]
Portfolio companies
 |
- 3Scan
- AltspaceVR
- BrightSky Labs
- Cambrios
- CloudMedx Inc
- Cerulean Pharma [NASDAQ:CERU]
- Crystal IS
- CyPhy Works
- Echodyne
- Everspin Technologies
- Experiment
- Genocea Biosciences [NASDAQ:GNCA]
- Gridco
- Halo Neuroscience
- Kala Pharmaceuticals
- Kurion
- Kymeta
- Kyruus
- Latch
- Lensbricks
- Luxtera
- Matterport
- Moment
- Mythic AI
- Nanosys
- Orbital Insight
- Pager
- Plethora
- Planet Labs
- Nanosys
- Nervana Systems
- Scaled Inference
- Siluria Technologies
- Sols
- Transphorm
- Visterra
- Vium
See also
- Entrepreneurship
- Venture Capital
- Startup company
References
- OCLC 11620213. Archived from the original on 2010-01-27.)
{{cite journal}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help - OCLC 132936538.
- ^ Kosoff, Maya (2 April 2015). "Venture firm Lux just got $350 million more to invests in robots, the future, and science". Business Insider. Retrieved 8 June 2015.
- ^ de la Merced, Michael (2 April 2015). "Lux Capital Raises $350 Million Fund to Back Science Start-Ups". New York Times. Retrieved 8 June 2015.
- ^ a b "Our Story". Lux Website. 14 June 2015.
- ^ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011.
- ^ "Kindler, Former Pfizer Chief, Joins Lux Capital". Dealbook. 8 August 2012.
External links
  | This article about a private equity or venture capital firm based in the United States is a stub. You can help Wikipedia by expanding it. |